Healthcare -
Biotechnology - NASDAQ - US
$ 1.9
-1.04 %
$ 398 M
Market Cap
-1.23
P/E
ALLO - CHANGE IN WORKING CAPITAL
Change in Working Capital ALLO - Allogene Therapeutics, Inc.
-15.3 M
LAST VALUE
30.94%
2 YEAR CAGR
-17.77%
5 YEAR CAGR
0.00%
10 YEAR CAGR